Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamila Wojas-Krawczyk

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|December 17, 2020
Imperfect Predictors for Lung Cancer Immunotherapy-A Field for Further ResearchKamila Wojas-Krawczyk, Tomasz Kubiatowski
International Journal of Molecular Sciences|December 30, 2025
<i>MTAP</i> Deletion as a Therapeutic Vulnerability in Cancer: From Molecular Mechanism to Clinical TargetingPaweł Krawczyk, Kamila Wojas-Krawczyk
Molecules (Basel, Switzerland)|July 15, 2020
Aptamers in Non-Small Cell Lung Cancer TreatmentIrena Wieleba, Kamila Wojas-Krawczyk, Paweł Krawczyk
Frontiers in Oncology|August 26, 2021
Viral Infection and Lung Cancer ImmunotherapyEwa Kalinka, Izabela Chmielewska, Kamila Wojas-Krawczyk
Cancers|July 14, 2023
Double Guard Efficiency and Safety-Overcoming Resistance to Immunotherapy by Blocking or Stimulating Several Immune Checkpoints in Non-Small Cell Lung Cancer PatientsEwa Kalinka, Kamila Wojas-Krawczyk, Paweł Krawczyk
International Journal of Molecular Sciences|August 27, 2021
Failure of Immunotherapy-The Molecular and Immunological Origin of Immunotherapy Resistance in Lung CancerJustyna Błach, Kamila Wojas-Krawczyk, Marcin Nicoś, et al.
Cancers|July 2, 2021
Two Complementarity Immunotherapeutics in Non-Small-Cell Lung Cancer Patients-Mechanism of Action and Future ConceptsKamila Wojas-Krawczyk, Paweł Krawczyk, Michał Gil, et al.
International Journal of Molecular Sciences|February 26, 2022
Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro CulturesIrena Wieleba, Kamila Wojas-Krawczyk, Paweł Krawczyk, et al.
Biology|June 24, 2022
Tumor Microenvironment-A Short Review of Cellular and Interaction DiversityAleksandra Bożyk, Kamila Wojas-Krawczyk, Paweł Krawczyk, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|October 16, 2015
Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques--the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted TherapiesMarcin Nicoś, Kamila Wojas-Krawczyk, Paweł Krawczyk, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|December 17, 2020
Imperfect Predictors for Lung Cancer Immunotherapy-A Field for Further ResearchKamila Wojas-Krawczyk, Tomasz Kubiatowski
International Journal of Molecular Sciences|December 30, 2025
<i>MTAP</i> Deletion as a Therapeutic Vulnerability in Cancer: From Molecular Mechanism to Clinical TargetingPaweł Krawczyk, Kamila Wojas-Krawczyk
Molecules (Basel, Switzerland)|July 15, 2020
Aptamers in Non-Small Cell Lung Cancer TreatmentIrena Wieleba, Kamila Wojas-Krawczyk, Paweł Krawczyk
Frontiers in Oncology|August 26, 2021
Viral Infection and Lung Cancer ImmunotherapyEwa Kalinka, Izabela Chmielewska, Kamila Wojas-Krawczyk
Cancers|July 14, 2023
Double Guard Efficiency and Safety-Overcoming Resistance to Immunotherapy by Blocking or Stimulating Several Immune Checkpoints in Non-Small Cell Lung Cancer PatientsEwa Kalinka, Kamila Wojas-Krawczyk, Paweł Krawczyk
International Journal of Molecular Sciences|August 27, 2021
Failure of Immunotherapy-The Molecular and Immunological Origin of Immunotherapy Resistance in Lung CancerJustyna Błach, Kamila Wojas-Krawczyk, Marcin Nicoś, et al.
Cancers|July 2, 2021
Two Complementarity Immunotherapeutics in Non-Small-Cell Lung Cancer Patients-Mechanism of Action and Future ConceptsKamila Wojas-Krawczyk, Paweł Krawczyk, Michał Gil, et al.
International Journal of Molecular Sciences|February 26, 2022
Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro CulturesIrena Wieleba, Kamila Wojas-Krawczyk, Paweł Krawczyk, et al.
Biology|June 24, 2022
Tumor Microenvironment-A Short Review of Cellular and Interaction DiversityAleksandra Bożyk, Kamila Wojas-Krawczyk, Paweł Krawczyk, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|October 16, 2015
Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques--the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted TherapiesMarcin Nicoś, Kamila Wojas-Krawczyk, Paweł Krawczyk, et al.
Pageof 7